купить онлайн купить в озон

Публикации

скачать Противовирусная активность глицерретовой и глицирризиновой кислот. Инфекция и иммунитет. - Т. 6, - № 3. - с. 199–206. Глицирризиновая кислота проявляет активность против широкого спектра вирусов, включая коронавирус, герпес вирусы, вирус гриппа А и ряд других.
скачать Онкоксин. Публикации по отдельным компонентам, входящим в состав 1. Alkan A., Mızrak D., Utkan G1. Lower folate levels in gastric cancer: is it a cause or a result? // World J Gastroenterol. 2015. 21(13). p. 4101-4102.

2. Ames B.N. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer //Mutat Res. 2001. 18. 475(1-2). p. 7-20.

3. Bak Y.K., Lampe J.W., Sung M.K. Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis // J
GastroenterolHepatol. 2014. 29(5). p. 957-963.

4. Bell G.A., Kantor E.D., Lampe J.W., Shen D.D., White E. Use of glucosamine and chondroitin in relation to mortality // Eur J Epidemiol. 2012. 27(8). p. 593-603.

5. Bosetti C., Scotti L., Maso L.D., Talamini R., Montella M., Negri E., Ramazzotti V., Franceschi S., Vecchia C.L. Micronutrients and the risk of renal cell cancer: A case–control study from Italy //Int J Cancer. 2007. 15.120(4). p. 892–896.

6. Bostanci Z., Mack R.P., Lee S., Soybel D.I., Kelleher S.L. Paradoxical zinc toxicity and oxidative stress in the mammary gland during marginal dietary zinc deficiency // ReprodToxicol. 2015. 54. p. 84-92.

7. Braga M, Sandrucci S. Perioperative nutrition in cancer patients. Eur J Surg Oncol. 2016 Jun;42(6):751-3. doi: 10.1016/j.ejso.2016.02.006. Epub 2016 Feb 18.

8. Buijs N., Luttikhold J., Houdijk A.P., van Leeuwen P.A. The role of a disturbed arginine/NO metabolism in the onset of cancer cachexia: a working hypothesis // Curr Med Chem. 2012. 19(31). p. 5278-5286.

9. Cao Z.X., Zhao Z.F., Zhao X.F. Effect of compound glycyrrhizin injection on liver function and cellular immunity of children with infectious mononucleosis complicated liver impairment // Chin J Integr Med. 2006. 12(4). p. 268-272.

10. Chow O, Barbul A. Immunonutrition: Role in Wound Healing and Tissue Regeneration. Adv Wound Care (New Rochelle). 2014 Jan 1;3(1):46-53.

11. Chueh F.S., Hsiao Y.T., Chang S.J., Wu P.P., Yang J.S., Lin J.J., Chung J.G., Lai T.Y. Glycyrrhizic acid induces apoptosis in WEHI-3 mouse leukemia cells through the caspase- and mitochondria-dependent pathways // Oncol Rep. 2012. 28(6). p. 2069-2076.

12. Ciacio O1, Voron T, Pittau G, Lewin M et al. Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial. BMC Cancer. 2014 Dec 18;14:980.

13. Cichoń T., Smolarczyk R., Matuszczak S., Barczyk M., Jarosz M., Szala S. D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice // Arch ImmunolTherExp (Warsz). 2014. 62(4). p. 341-351.

14. Ciubotariu D., Ghiciuc C.M., Lupușoru C.E. Zinc involvement in opioid addiction and analgesia—should zinc supplementation be recommended for opioid-treated persons? // Subst Abuse Treat Prev Policy. 2015. 4;10:29.Sweeney J.D., Ziegler P., Pruet C., Spaulding M.B. Hyperzincuria and hypozincemia in patients treated with cisplatin // Cancer. 1989. 63(11). p. 2093-2095.

15. Cohen J., Chin W.D. Nutrition and sepsis // World Rev Nutr Diet. 2013. 105. p. 116-125.

16. D’Arena G., Simeon V., De Martino L., Statuto T., D’Auria F., Volpe S., Deaglio S., Maidecchi A., Mattoli L., Mercati V., Musto P., De Feo V. Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia //Int J ImmunopatholPharmacol. 2013. 26(1). p. 117-125.

17. Dias Rodrigues V, Barroso de Pinho N, Abdelhay E, Viola JP et al. Nutrition and Immune-Modulatory Intervention in Surgical Patients With Gastric Cancer. Nutr Clin Pract. 2016 Jun 21. pii: 0884533616653807. [Epub ahead of print]

18. Díaz-Flores M., Cruz M., Duran-Reyes G., Munguia-Miranda C., Loza-Rodríguez H., Pulido-Casas E., Torres-Ramírez N., Gaja-Rodriguez O., Kumate J., Baiza-Gutman L.A., Hernández-Saavedra D. Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure // Can J PhysiolPharmacol. 2013. 91(10). p. 855-860.

19. Dominiak K., McKinney J., Heilbrun L.K., Sarkar F.H. Critical need for clinical trials: an example of a pilot human intervention trial of a mixture of natural agents protecting lymphocytes against TNF-alpha induced activation of NF-kappaB //Pharm Res. 2010. 27(6). p. 1061-1065.

20. Dryden G.W., Lam A., Beatty K., Qazzaz H.H., McClain C.J. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis // Inflamm Bowel Dis. 2013. 19(9) p. 1904-1912.

21. Finaud J., Lac G., Filaire E. Oxidative stress: relationship with exercise and training// Sports Med. 2006. 36(4). p. 327–358.

22. Friedman B.J., Freeland-Graves J.H., Bales C.W., Behmardi F., Shorey-Kutschke R.L., Willis R.A., Crosby J.B., Trickett P.C., Houston S.D. Manganese balance and clinical observations in young men fed a manganese-deficient diet // J Nutr. 1987. 117(1). p. 133-143.

23. Fukagawa N.K., Galbraith R.A. Advancing age and other factors influencing the balance between amino acid requirements and toxicity // J Nutr. 2004. 134(6 Suppl). p. 1569-1574.

24. Gade J, Levring T, Hillingsø J, Hansen CP, Andersen JR. The Effect of Preoperative Oral Immunonutrition on Complications and Length of Hospital Stay After Elective Surgery for Pancreatic Cancer-A Randomized Controlled Trial. Nutr Cancer. 2016 Feb-Mar;68(2):225-33.

25. Galas A, Kulig P, Kulig J. Dietary inflammatory index as a potential determinant of a length of hospitalization among surgical patientstreated for colorectal cancer. Eur J Clin Nutr. 2014 Oct;68(10):1168-74.

26. Giger U., Büchler M., Farhadi J., Berger D., Hüsler J., Schneider H., Krähenbühl S., Krähenbühl L. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study // Ann SurgOncol. 2007. 14(10). p. 2798-2806.

27. Grotz M.R., Pape H.C., van Griensven M., Stalp M., Rohde F., Bock D., Krettek C. Glycine reduces the inflammatory response and organ damage in a two-hit sepsis model in rats // Shock. 2001. 16(2). p. 116-121.

28. Gupta N., Saleem A., Kotz B., Osman S. et al. Carbogen and nicotinamide increase blood flow and 5–fluorouracil delivery but not 5–fluorouracil retention in colorectal cancer metastases in patients //Clin Cancer Res. 2006. 15;12(10). p. 3115–3123.

29. Haase H., Rink L. Signal transduction in monocytes: the role of zinc ions // Biometals. 2007. 20(3-4). p. 579-585.

30. Ham D.J., Murphy K.T., Chee A., Lynch G.S.1, Koopman R. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia //ClinNutr. 2014. 33(3). p. 448-458.

31. He S.Q., Gao M., Fu Y.F., Zhang Y.N. Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling //Int J ClinExpPathol. 2015. 8(5). p. 5175-5181.

32. Hébuterne X., Lemarié E., Michallet M., de Montreuil C.B., Schneider S.M., Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer // J Parenter Enteral Nutr. 2014. 38(2). p. 196-204.

33. Hoensch H., Groh B., Edler L., Kirch W. Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence // World J Gastroenterol. 2008. 14(14). p. 2187-2193.

34. Huang R.Y., Chu Y.L., Jiang Z.B., Chen X.M., Zhang X., Zeng X. Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase // Cell PhysiolBiochem. 2014. 33(2). p. 375-388.

35. Ikeda K., Kawamura Y., Kobayashi M., Fukushima T., Sezaki H., Hosaka T., Akuta N., Saitoh S., Suzuki F., Suzuki Y., Arase Y., Kumada H. Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov model // Oncology. 2014. 86(5-6). p. 295-302.

36. Kantor E.D., Lampe J.W., Navarro S.L., Song X., Milne G.L., White E. Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation // J Altern Complement Med. 2014. 20(6). p. 479-485.

37. Khan R., Khan A.Q., Lateef A., Rehman M.U., Tahir M., Ali F., Hamiza O.O., Sultana S. Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats // PLoS One. 2013. 8(2). p. 56020.

38. Kitamura H., Morikawa H., Kamon H., Iguchi M., Hojyo S., Fukada T., Yamashita S., Kaisho T., Akira S., Murakami M., Hirano T. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function // Nat Immunol. 2006. 7(9). p. 971-977.

39. Koga K., Kawashima S., Shibata N., Takada K. Novel formulations of a liver protection drug glycyrrhizin //YakugakuZasshi. 2007. 127(7). p. 1103-1114.

40. Konzack A., Jakupovic M., Kubaichuk K., Görlach A., Dombrowski F., Miinalainen I., Sormunen R., Kietzmann T. Mitochondrial dysfunction due to lack of manganese superoxide dismutase promotes hepatocarcinogenesis //Antioxid Redox Signal. 2015. [Epub ahead of print].

41. Lajous M., Lazcano–Ponce E., Hernandez–Avila M., et al Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women // Cancer Epidemiol Biomarkers Prev. 2006. 15(3). p. 443–448.

42. Lee T.Y., Chiang E.P., Shih Y.T., Lane H.Y., Lin J.T., Wu C.Y. Lower serum folate is associated with development and invasiveness of gastric cancer // World J Gastroenterol. 2014. 20(32). p. 11313-11320.

43. Li S., Zhu J.H., Cao L.P., Sun Q., Liu H.D., Li W.D., Li J.S., Hang C.H. Growth inhibitory in vitro effects of glycyrrhizic acid in U251 glioblastoma cell line // Neurol Sci. 2014. 35(7). p. 1115-1120.

44. Liu M., Xu Y.F., Feng Y., Yang F.Q., Luo J., Zhai W., Che J.P., Wang G.C., Zheng J.H. Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors // J Surg Res. 2013. 183(1). p. 397-404.

45. Manns M.P., Wedemeyer H., Singer A., Khomutjanskaja N., Dienes H.P., Roskams T., Goldin R., Hehnke U., Inoue H.; European SNMC Study Group. Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks // J Viral Hepat. 2012. 19(8). p. 537-546.

46. Mariette C. Immunonutrition. J Visc Surg. 2015 Aug;152 Suppl 1:S14-7.

47. Mauriz J.L., Matilla B., Culebras J.M., González P., González-Gallego J. Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat // Free RadicBiol Med. 2001. 15.31(10). p. 1236-1244.

48. Mauskopf JA, Candrilli SD, Chevrou-Séverac H, Ochoa JB. Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs. World J Surg Oncol. 2012 Jul 6;10:136.

49. McCarty M.F. Preclinical Studies Suggest Complex Nutraceutical Strategies May Have Potential for Preventing and Managing Sepsis // AlternTher Health Med. 2015. 21 Suppl 2. p. 56-67.

50. Miller G.W., Lock E.A., Schnellmann R.G. Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury // ToxicolApplPharmacol. 1994. 125(2). p. 192-197.

51. Moses M.A., Henry E.C., Ricke W.A., GasiewiczT.A.The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model // Cancer Prev Res (Phila). 2015. 8(3). p. 249-257.

52. Murakami M., Hirano T. Intracellular zinc homeostasis and zinc signaling // Cancer Sci. 2008. 99(8). p. 1515-1522.

53. Nagata S, Shirabe K, Sugimachi K, Ikegami T et al. Pilot study of preoperative immunonutrition with antioxidants in living donor liver transplantation donors. Fukuoka Igaku Zasshi. 2013 Dec;104(12):530-8.

54. Nguyen D., Hsu J.W., Jahoor F., Sekhar R.V. Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients // J ClinEndocrinolMetab. 2014. 99(1). p. 169-177.

55. Pathak S., Bajpai D., Banerjee A., Bhatla N., Jain S.K., Jayaram H.N., Singh N. Serum one-carbon metabolites and risk of cervical cancer // Nutr Cancer. 2014. 66(5). p. 818-824.

56. Pelucchi C., Galeone C., Talamini R., Negri E., Parpinel M., Franceschi S., Montella M., La Vecchia C. Dietary folate and risk of prostate cancer in Italy // Cancer Epidemiol Biomarkers Prev. 2005 14(4). p. 944-948.

57. PerumalS.S.,ShanthiP., SachdanandamP. Energy–modulating vitamins – a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma // Br J Nutr. 2005. 93(6). р. 901–909.

58. Prasad A.S. Impact of the discovery of human zinc deficiency on health //J Trace Elem Med Biol. 2014. 28(4). p. 357-363.

59. Prasad A.S. Zinc in human health: effect of zinc on immune cells // Mol Med. 2008. 14(5-6). p. 353-357.

60. Prasad A.S. Zinc: mechanisms of host defense // JNutr. 2007. 137(5):1345-9.

61. Robbins D., Zhao Y. Manganese superoxide dismutase in cancer prevention // Antioxid Redox Signal. 2014. 20(10). p. 1628-1645.

62. Rolandelli R.H., Bankjhead R., Boullata J.I., Compher C.W. Clinical Nutrition. Enteral and Tube Feeding// Philadelphia. 2004. 672 p.

63. Rose ML., Madren J., Bunzendahl H., Thurman R.G. Dietary glycine inhibits the growth of B16 melanoma tumors in mice // Carcinogenesis. 1999. 20(5). p. 793-798.

64. Rusyn I., Bradham C.A., Cohn L., Schoonhoven R., Swenberg J.A., Brenner D.A., Thurman R.G. Corn oil rapidly activates nuclear factor-kappaB in hepatic Kupffer cells by oxidant-dependent mechanisms // Carcinogenesis. 1999. 20(11). p. 2095-2100.

65. Schernhammer E., Wolpin B., Rifai N., Cochrane B., Manson J.A., Ma J., Giovannucci E., Thomson C., Stampfer M.J., Fuchs C. Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts // Cancer Res. 2007. 67(11). p. 5553-5560.

66. Schernhammer E.S., Ogino S., Fuchs C.S. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expressio // Gastroenterology. 2008. 135(3). p. 770-780.

67. Shanafelt T.D., Call T.G., Zent C.S., LaPlant B., Bowen D.A., Roos M., Secreto C.R., Ghosh A.K., Kabat B.F., Lee M.J., Yang C.S., Jelinek D.F., Erlichman C., Kay N.E. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia // J ClinOncol. 2009. 27(23). p. 3808-3814.

68. Shanafelt T.D., Call T.G., Zent C.S., Leis J.F., LaPlant B., Bowen D.A., Roos M., Laumann K., Ghosh A.K., Lesnick C., Lee M.J., Yang C.S., Jelinek D.F., Erlichman C., Kay N.E. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia // Cancer. 2013. 119(2). p. 363-370.

69. Shankar A.H., Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection // Am J ClinNutr. 1998. 68. p. 447-463.

70. Song GM, Tian X, Liang H, Yi LJ et al. Role of Enteral Immunonutrition in Patients Undergoing Surgery for Gastric Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2015 Aug;94(31):e1311.

71. Song GM, Tian X, Zhang L, Ou YX et al. Immunonutrition Support for Patients Undergoing Surgery for Gastrointestinal Malignancy: Preoperative, Postoperative, or Perioperative? A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2015 Jul;94(29):e1225.

72. Talvas J, Garrait G, Goncalves-Mendes N, Rouanet J et al. Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. Clin Nutr. 2015 Oct;34(5):810-7.

73. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V., Hochberg M.C., Wells G. Glucosamine therapy for treating osteoarthritis // Cochrane Database Syst Rev. 2005. (2). CD002946.

74. Vannini F., Kashfi K., Nath N. The dual role of iNOSin cancer // Redox Biol. 2015. 24;6. p. 334-343.

75. Veldt B.J., Hansen B.E., Ikeda K., Verhey E., Suzuki H., Schalm S.W. Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon //Scand J Gastroenterol. 2006. 41(9). p. 1087-1094.

76. Weinstein S.J., Stolzenberg–Solomon R. et al. Dietary factors of one–carbon metabolism and prostate cancer risk // Am J ClinNutr. 2006. 84(4). p.929–935.

77. Whitehead V.M. Acquired and inherited disorders of cobalamin and folate in children // Br J Haematol. 2006.134(2).p.125–136.

78. Woo M., Park K., Nam J., Kim J.C. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer // J GastroenterolHepatol. 2007. 22(7). p. 1064-1070.

79. Xie J., Owen T., Xia K., Singh A.V., Tou E., Li L., Arduini B., Li H., Wan L.Q., Callahan B., Wang C. Zinc inhibits Hedgehog autoprocessing: linking zinc deficiency with Hedgehog activation // J Biol Chem. 2015. 1;290(18). p. 11591-11600.

80. Yagi T., Asakawa A., Ueda H., Ikeda S., Miyawaki S., Inui A. The role of zinc in the treatment of taste disorders // Recent Pat Food Nutr Agric. 2013. 5(1). p. 44-51.

81. Yan Y., Mo Y., Zhang D. Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors // ZhonghuaGanZang Bing ZaZhi. 2015. 23(3). p. 204-208.

82. Yasui S., Fujiwara K., Tawada A., Fukuda Y., Nakano M., Yokosuka O. Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis // Dig Dis Sci. 2011. 56(12). p. 3638-3647.

83. Yoon J.Y., Kwon H.H., Min S.U., Thiboutot D.M., Suh D.H. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes // J Invest Dermatol. 2013. 133(2). p. 429-440.

84. Zhao H., Xie P., Li X., Zhu W., Sun X., Sun X., Chen X., Xing L., Yu J. A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer // RadiotherOncol. 2015. 114(3). p. 351-356.

85. Zhao H., Zhu W., Xie P., Li H., Zhang X., Sun X., Yu J., Xing L. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer // RadiotherOncol. 2014. 110(1). p. 132-136.

86. Zhong Z., Li X., Yamashina S., von Frankenberg M., Enomoto N., Ikejima K., Kolinsky M., Raleigh J.A., Thurman R.G. Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine // J PharmacolExpTher. 2001. 299(3). p. 858-865.

87. Zhong Z., Wheeler M.D., Li X., Froh M., Schemmer P., Yin M., Bunzendaul H., Bradford B., Lemasters J.J. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent // CurrOpinClinNutrMetab Care. 2003. 6(2). p. 229-240.

88. Grebenkina E.V., Grechkanev G.O. Nutritional supplementation in complex treatment of patients with gynecologic cancers / Nizhniy Novgorod Medical Journal 2006.N7. p. 72-76 (Russian).

89. Gromova O.A., Rebrov V.G. Vitamins and cancerogenesis / RMJ. 2007. N9. p.34-39 (Russian).

90. Khadyshyan G.G. Nutritional supplementation for cancer patients using peptide cocktails / Lechashiy Vrach 2005. N 2 . p. 14-15 (Russian).

91. Snegovoy A.V., Saltanov A.I., Manzuk L.V., Selchuck V.U. Nutritional deficiency and methods for its treatment in cancer patients / Practical oncology, 2009 Т10. No1. p. 49-57 (Russian).

92. Snegovoy A.V., Saltanov A.I., Manzuk L.V., Selchuck V.U. Nutritional supplementation for chemotherapy / RMJ, 2008.T 16. No27. p. 1818-1824 (Russian).

Обратите внимание, в ряде стран ОНКОКСИН распространяется под следующими торговыми наименованиями: Oncoxin+Viusid, Ocoxin, Ocoxin+Viusid, Ocoxin-Viusid.

Получайте полезные советы по почте

Советы и подсказки

Проблемы с питанием и пищеварением

Рекомендации по питанию при онкологических заболеваниях

РЕКОМЕНДАЦИИ ПО ПИТАНИЮ ПРИ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЯХ. Скачать одним файлом.

Мастопатия

МАСТОПАТИЯ. И опять о ней. Часть 1.

Последние новости

15 сентября 2022
РАК ЯИЧНИКОВ. КАЧЕСТВО ЖИЗНИ.
27 июля 2021
Аппетит во время и после химиотерапии онкологических заболеваний.
9 июля 2021
Глицирризин блокирует репликацию вируса SARS-CoV-2, ингибируя основную вирусную протеазу Mpro.